Previous 10 | Next 10 |
Arena Pharmaceuticals, Inc. (ARNA) Jefferies Next Generation IBD Therapeutics Virtual Summit September 23, 2020 13:45 ET Corporate Participants Amit Munshi - Chief Executive Officer Conference Call Participants Chris Howerton - Jefferies Presentation Chris Howerton Hi, everyone. My name is Ch...
SAN DIEGO , Sept. 18, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi , the Company's President and Chief Executive Officer, will present a corporate update at the Jefferies Virtual Next Generation IBD Therapeutics Summit on...
Arena Pharmaceuticals, Inc. (ARNA) Cantor 2020 Global Virtual Healthcare Conference September 16, 2020 02:00 PM ET Company Participants Amit Munshi - Director, President & Chief Executive Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Presentation...
Arena Pharmaceuticals (NASDAQ: ARNA ) has dosed the first participant in the ELEVATE UC 12 global Phase 3 trial evaluating etrasimod, as the potential treatment of moderately to severely active ulcerative colitis (UC). More news on: Arena Pharmaceuticals, Inc., Healthcare stocks news, ...
- Evaluating etrasimod 2 mg in patients with the clinical diagnosis of moderately to severely active ulcerative colitis (UC) - Significant unmet need for new effective oral therapies in UC SAN DIEGO , Sept. 16, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) toda...
Arena Pharmaceuticals, Inc. (ARNA) H.C. Wainwright Virtual Global Investment Conference September 14, 2020 10:00 A.M. ET Company Participants Amit Munshi - Director, President, Chief Executive Officer Conference Call Participants Patrick Trucchio - H.C. Wainwright & Co. ...
CannabisNewsWire Editorial Coverage : A recent Data Bridge Market Research report notes that the once-hot cannabis industry looks to be heating up again — in a big way. The report includes predictions that the global legal marijuana market will total more than $90 billion by 2027. Sm...
Arena Pharmaceuticals, Inc. (ARNA) Wells Fargo Securities 2020 Virtual Healthcare Conference September 09, 2020, 1:20 pm ET Executives Amit Munshi - Director, President, Chief Executive Officer Analysts Nick Abbott - Wells Fargo Securities Presentation Operator Welcom...
The first participant has been dosed in a Phase 2 clinical trial evaluating Arena Pharmaceuticals' (NASDAQ: ARNA ) lead drug etrasimod in patients with moderate-to-severe alopecia areata , an autoimmune disorder characterized by hair loss. More news on: Arena Pharmaceuticals, Inc., He...
SAN DIEGO , Sept. 1, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the first subject has been dosed in a Phase 2 trial evaluating etrasimod, an investigational, next-generation, once-daily, oral, selective sphingosine 1-phosphate (S1P) receptor mod...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...